Shares of Edinburgh-based Craneware, a software firm that specializes in the US healthcare market, rose about 6% after it said in a trading update that it expects to report 15% increases in both revenue and adjusted EBITDA for the six month period ended December 31, 2016.

“With the growth in the period, continued cash generation and a healthy sales pipeline, the board is confident in meeting market expectations for the full year,” said Craneware.

The company will announce results for the six months ended December 31 on March 7.

Craneware CEO Keith Neilson said: “There is continued consensus in the US of the need to drive value in healthcare with ongoing support for the move to value-based care and increasing consumerism.

“An impending change of government always brings with it an element of uncertainty, it was therefore particularly pleasing to see the acceleration in sales of our value cycle solutions post the result of the US Presidential election.

“Our value cycle software continues to help US Healthcare providers meet the challenges they will face as they navigate the ongoing re-imbursement model changes.   

“We continue to invest in both our current solutions and in the new products we are developing to expand our support to US healthcare providers as they pursue quality patient outcomes and optimal financial performance.

“These supportive market drivers, our investment for the future and our continued profitable growth, give management confidence in its ability to deliver continued stakeholder value.”